Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Arbovirus Infections | 4 | 2018 | 104 | 1.10 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.54 | Why? |
| Horse Diseases | 1 | 2015 | 101 | 0.53 | Why? |
| Goats | 1 | 2014 | 217 | 0.52 | Why? |
| Nasopharynx | 3 | 2021 | 10224 | 0.50 | Why? |
| Horses | 1 | 2015 | 474 | 0.50 | Why? |
| Chickenpox Vaccine | 1 | 2013 | 59 | 0.49 | Why? |
| Viral Load | 7 | 2021 | 15850 | 0.46 | Why? |
| Measles virus | 1 | 2013 | 194 | 0.44 | Why? |
| Residence Characteristics | 1 | 2021 | 1927 | 0.41 | Why? |
| Measles-Mumps-Rubella Vaccine | 1 | 2013 | 282 | 0.40 | Why? |
| Communicable Diseases, Imported | 1 | 2018 | 843 | 0.39 | Why? |
| Camelus | 2 | 2016 | 1425 | 0.37 | Why? |
| Adaptive Immunity | 1 | 2020 | 2585 | 0.37 | Why? |
| Virus Shedding | 3 | 2021 | 5834 | 0.35 | Why? |
| Arboviruses | 2 | 2018 | 76 | 0.34 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.33 | Why? |
| RNA, Viral | 5 | 2021 | 32276 | 0.33 | Why? |
| Virus Replication | 5 | 2020 | 14331 | 0.31 | Why? |
| Viral Tropism | 1 | 2013 | 1329 | 0.29 | Why? |
| Epithelial Cells | 2 | 2018 | 3508 | 0.29 | Why? |
| Seizures | 1 | 2013 | 1163 | 0.27 | Why? |
| Host Specificity | 3 | 2018 | 926 | 0.24 | Why? |
| Kinetics | 2 | 2021 | 3238 | 0.24 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.24 | Why? |
| Travel | 3 | 2018 | 7220 | 0.23 | Why? |
| Antibodies, Viral | 13 | 2021 | 51949 | 0.23 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 4 | 2016 | 8843 | 0.22 | Why? |
| Switzerland | 4 | 2021 | 2738 | 0.22 | Why? |
| Apolipoprotein A-I | 1 | 2021 | 148 | 0.21 | Why? |
| Coronavirus | 5 | 2020 | 18339 | 0.20 | Why? |
| Coronavirus Infections | 19 | 2020 | 253789 | 0.20 | Why? |
| Artifacts | 1 | 2020 | 250 | 0.18 | Why? |
| Immunoassay | 4 | 2021 | 4485 | 0.17 | Why? |
| Respiratory Tract Infections | 2 | 2015 | 6817 | 0.16 | Why? |
| Virus Cultivation | 1 | 2020 | 579 | 0.16 | Why? |
| Child | 11 | 2021 | 70012 | 0.16 | Why? |
| Clinical Medicine | 1 | 2017 | 93 | 0.15 | Why? |
| Betacoronavirus | 12 | 2020 | 204454 | 0.15 | Why? |
| Picornaviridae | 1 | 2015 | 123 | 0.14 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.14 | Why? |
| Europe | 7 | 2021 | 12702 | 0.14 | Why? |
| Influenza A virus | 2 | 2018 | 2234 | 0.14 | Why? |
| Cell Line | 4 | 2020 | 12040 | 0.14 | Why? |
| Clinical Laboratory Techniques | 6 | 2020 | 23402 | 0.14 | Why? |
| Sensitivity and Specificity | 8 | 2021 | 22971 | 0.13 | Why? |
| Professional Competence | 1 | 2017 | 246 | 0.13 | Why? |
| Acute Kidney Injury | 1 | 2013 | 5762 | 0.13 | Why? |
| Humans | 40 | 2021 | 930598 | 0.13 | Why? |
| Vaccines, Combined | 1 | 2013 | 67 | 0.13 | Why? |
| Seroepidemiologic Studies | 4 | 2021 | 10017 | 0.12 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.12 | Why? |
| Ghana | 1 | 2015 | 763 | 0.12 | Why? |
| Child, Preschool | 6 | 2021 | 36283 | 0.12 | Why? |
| Middle East | 2 | 2014 | 1418 | 0.11 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.11 | Why? |
| Serum | 1 | 2013 | 294 | 0.11 | Why? |
| Adult | 13 | 2021 | 244371 | 0.11 | Why? |
| Respiratory Syncytial Viruses | 1 | 2015 | 612 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.11 | Why? |
| Family Characteristics | 1 | 2021 | 2551 | 0.10 | Why? |
| Gastroenteritis | 1 | 2015 | 489 | 0.10 | Why? |
| Urine | 1 | 2013 | 469 | 0.10 | Why? |
| Picornaviridae Infections | 1 | 2015 | 544 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Reagent Kits, Diagnostic | 1 | 2020 | 2149 | 0.10 | Why? |
| Cells, Cultured | 3 | 2018 | 5835 | 0.10 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.09 | Why? |
| Rhinovirus | 1 | 2015 | 979 | 0.09 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.09 | Why? |
| Respiratory System | 1 | 2021 | 3213 | 0.09 | Why? |
| Infant | 4 | 2021 | 30274 | 0.09 | Why? |
| Coronaviridae | 1 | 2013 | 923 | 0.08 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.08 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.08 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2015 | 11367 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| Civil Defense | 1 | 2017 | 1687 | 0.07 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.07 | Why? |
| Disease Reservoirs | 1 | 2015 | 1672 | 0.07 | Why? |
| Pharynx | 1 | 2013 | 1544 | 0.07 | Why? |
| Respiratory Syncytial Virus Infections | 1 | 2015 | 1234 | 0.07 | Why? |
| Virus Attachment | 1 | 2012 | 1259 | 0.07 | Why? |
| Male | 13 | 2021 | 367725 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2020 | 13720 | 0.07 | Why? |
| Infant, Newborn | 3 | 2021 | 23105 | 0.07 | Why? |
| Antibodies, Neutralizing | 5 | 2021 | 25288 | 0.07 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2018 | 7220 | 0.06 | Why? |
| SARS Virus | 2 | 2020 | 13021 | 0.06 | Why? |
| Chiroptera | 1 | 2018 | 3530 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| DNA Primers | 2 | 2020 | 1170 | 0.06 | Why? |
| Base Sequence | 3 | 2016 | 3581 | 0.06 | Why? |
| Leukemia, Lymphoid | 1 | 2021 | 20 | 0.06 | Why? |
| Bendamustine Hydrochloride | 1 | 2021 | 41 | 0.06 | Why? |
| Spain | 1 | 2020 | 15545 | 0.06 | Why? |
| Vero Cells | 2 | 2016 | 14117 | 0.06 | Why? |
| Antineoplastic Agents, Alkylating | 1 | 2021 | 71 | 0.06 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.05 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.05 | Why? |
| Genotype | 1 | 2013 | 4697 | 0.05 | Why? |
| Animals | 6 | 2018 | 78931 | 0.05 | Why? |
| Coinfection | 1 | 2021 | 6820 | 0.05 | Why? |
| Female | 10 | 2021 | 380317 | 0.05 | Why? |
| Toll-Like Receptor 2 | 1 | 2021 | 198 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Receptors, Virus | 2 | 2018 | 5659 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| DNA Probes | 1 | 2020 | 178 | 0.05 | Why? |
| Saudi Arabia | 3 | 2016 | 4423 | 0.05 | Why? |
| Microfluidic Analytical Techniques | 1 | 2021 | 254 | 0.05 | Why? |
| Sequence Homology, Amino Acid | 1 | 2021 | 945 | 0.05 | Why? |
| Population Surveillance | 1 | 2015 | 4967 | 0.04 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.04 | Why? |
| Dried Blood Spot Testing | 1 | 2021 | 383 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2020 | 835 | 0.04 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Pathology, Molecular | 1 | 2020 | 343 | 0.04 | Why? |
| Virus Release | 1 | 2018 | 253 | 0.04 | Why? |
| Communicable Disease Control | 3 | 2021 | 29620 | 0.04 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2018 | 640 | 0.04 | Why? |
| Neuraminidase | 1 | 2018 | 289 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Sequence Homology, Nucleic Acid | 1 | 2016 | 368 | 0.04 | Why? |
| Viral Envelope Proteins | 2 | 2020 | 3539 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2021 | 11304 | 0.03 | Why? |
| Hedgehogs | 1 | 2013 | 56 | 0.03 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2021 | 830 | 0.03 | Why? |
| Host-Pathogen Interactions | 1 | 2014 | 11041 | 0.03 | Why? |
| Kenya | 1 | 2016 | 887 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Rituximab | 1 | 2021 | 1096 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Immunity, Herd | 1 | 2020 | 1011 | 0.03 | Why? |
| Caco-2 Cells | 1 | 2016 | 1236 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Endemic Diseases | 1 | 2016 | 480 | 0.03 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.03 | Why? |
| High-Throughput Screening Assays | 1 | 2021 | 1783 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| South Africa | 1 | 2021 | 3326 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| Mammals | 1 | 2012 | 315 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.03 | Why? |
| Delayed Diagnosis | 1 | 2020 | 1529 | 0.03 | Why? |
| Influenza, Human | 1 | 2015 | 10779 | 0.03 | Why? |
| Odds Ratio | 1 | 2021 | 5861 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2014 | 3198 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.02 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2021 | 3493 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2016 | 3608 | 0.02 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.02 | Why? |
| Surveys and Questionnaires | 1 | 2015 | 43792 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Laboratories | 1 | 2020 | 2858 | 0.02 | Why? |
| Coronavirus NL63, Human | 1 | 2012 | 669 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2015 | 2830 | 0.02 | Why? |
| Computational Biology | 1 | 2021 | 4514 | 0.02 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Open Reading Frames | 1 | 2012 | 1898 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Coronavirus OC43, Human | 1 | 2012 | 1157 | 0.02 | Why? |
| Coronavirus 229E, Human | 1 | 2012 | 1241 | 0.02 | Why? |
| Brazil | 1 | 2021 | 12582 | 0.02 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.02 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Feces | 1 | 2015 | 4235 | 0.01 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2014 | 3607 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2021 | 6166 | 0.01 | Why? |
| Germany | 1 | 2015 | 9196 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Viral Proteins | 1 | 2018 | 7370 | 0.01 | Why? |
| Phylogeny | 1 | 2016 | 13341 | 0.01 | Why? |
| Treatment Outcome | 1 | 2021 | 51732 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2017 | 9044 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Cross Infection | 1 | 2014 | 8675 | 0.01 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2012 | 9659 | 0.01 | Why? |
| Lung | 1 | 2018 | 31049 | 0.01 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.01 | Why? |
Eckerle's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(203)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(348)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_